Jun 10, 2024
Leukemia (Blood Cancer)
ALL is the commonest childhood cancer. The peak age is between 2-6 years. Boys are affected more frequently as compared to girls.
seen from United States
seen from United States
seen from Malaysia
seen from T1
seen from Russia
seen from United States
seen from Brazil
seen from Russia
seen from United States
seen from China
seen from Malaysia
seen from Türkiye
seen from United States
seen from Canada
seen from Malaysia
seen from T1
seen from China
seen from Malaysia
seen from United States
seen from Türkiye
Leukemia (Blood Cancer)
ALL is the commonest childhood cancer. The peak age is between 2-6 years. Boys are affected more frequently as compared to girls.
Explore the latest breakthroughs and treatments in the Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics Market. Discover innovati
Global Dasatinib Drugs Market Is Estimated To Witness High Growth Owing To Increasing Demand for Targeted Cancer Therapies
The global Dasatinib Drugs Market is estimated to be valued at US$ 4.35 billion in 2023 and is expected to exhibit a CAGR of 6.0% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights. Market Overview: Dasatinib is an oral medication used for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is classified as a tyrosine kinase inhibitor and works by blocking the action of abnormal proteins that signal the growth of cancer cells. The advantages of dasatinib include its high efficacy in treating CML, ability to target specific cancer cells, and reduced side effects compared to traditional chemotherapy. The increasing incidence of CML and the demand for targeted cancer therapies are driving the growth of the dasatinib drugs market. Market Key Trends: One key trend in the dasatinib drugs market is the growing focus on precision medicine. Precision medicine aims to tailor treatment strategies based on a patient's genetic makeup, lifestyle, and environmental factors. Dasatinib, being a targeted therapy, aligns with the principles of precision medicine by selectively inhibiting specific cancer cells, thereby reducing the likelihood of adverse effects. For example, research studies have identified specific mutations in the BCR-ABL gene, which can affect the response to dasatinib treatment. This trend emphasizes the importance of personalized therapies and molecular testing in optimizing patient outcomes. PEST Analysis: - Political: Government regulations and policies related to drug approvals, intellectual property rights, and reimbursement can significantly impact the availability and affordability of dasatinib drugs. - Economic: The cost-effectiveness of dasatinib drugs compared to other treatment options, as well as healthcare expenditure and insurance coverage, can influence market growth. - Social: The increasing prevalence of cancer, especially CML, and the awareness and acceptance of targeted therapies among patients and healthcare professionals are driving market demand. - Technological: Advances in genetic testing technologies and biomarker identification are enabling the identification of patients who are likely to benefit the most from dasatinib treatment. Key Takeaways: 1: The Global Dasatinib Drugs Market Demand is expected to witness high growth, exhibiting a CAGR of 6.0% over the forecast period, due to increasing demand for targeted cancer therapies. Dasatinib's efficacy in treating CML and its ability to selectively target specific cancer cells position it as a preferred treatment option. 2: In terms of regional analysis, North America is expected to dominate the dasatinib drugs market due to the high prevalence of CML in the region and the well-established healthcare infrastructure. Asia Pacific is projected to be the fastest-growing region, driven by the increasing incidence of CML and the rising adoption of targeted therapies. 3: Key players operating in the global dasatinib drugs market include Bristol-Myers Squibb Company, Novartis International AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Cipla Ltd., Hetero Drugs Limited, Natco Pharma Limited, Dr. Reddy's Laboratories Ltd., and Aurobindo Pharma Ltd. These companies focus on research and development activities to develop innovative therapies and expand their product portfolios.
Making a party out of cancer
New Story has been published on https://enzaime.com/making-party-cancer/
Making a party out of cancer
Every Sunday, the Cutter family holds a Chemofeast. The door to their home is open to any and all who wish to attend. It’s a day full of food, beverages, and a lot of laughter, and 15-year-old Blake Cutter gets to choose the menu. Then on Monday, his mother, Lois, drives him to chemotherapy at Dana-Farber.
For the Cutter family, which includes patients Lois and her 15-year-old son Blake, laughter is the best medicine. Blake was diagnosed with rhabdomyosarcoma, a soft-tissue cancer, back in February. It wasn’t the Cutters’ first encounter with cancer. That had come in April, 2011, when Lois learned she had breast cancer. After recovering from reconstructive surgery, she returned to work on January 31. Two weeks later, Blake was diagnosed. Lois knew what to do: make a party out of cancer. She organized a Chemofeast for Blake every Sunday before driving him to Dana-Farber for treatment the next day. Chemofeast isn’t about the food. From the beginning, the Cutters decided to “celebrate life” and surround themselves with positive energy from others. The Sunday festivities guide them through the rough spots of cancer treatment, allowing them to laugh and appreciate family and friends who love and support them. “I’m glad I got cancer so I could help Blake navigate his way through this,” says Lois. Cancer doesn’t scare her. In fact, her journey through cancer and that of many family members led her to fundraising. Every year, she raises money for the Jimmy Fund and other causes through her beauty salon and other events. Energy, optimism, and spirit are her trademarks. Once, when Lois was at Dana-Farber with a friend, they were laughing about how when doctors said something is “rare or unusual,” it seemed to happen to Lois. Another woman turned to her and remarked: “You remind me that I don’t smile and laugh enough. Thank you for showing me that today.” “Laughing is my number one hobby,” says Lois. “My treatment could have failed me. Instead, I’m standing here today with the ability to help other people, and see them happy.” That includes her son. Blake also had the help of an unlikely new friend, a 3-year-old boy undergoing treatment at the Jimmy Fund Clinic for acute lymphoblastic leukemia. The two met at a Red Sox game, and they’ve been best friends ever since. Despite the challenges she has faced, Lois is content. “I wake up every day, place my feet on the floor, and thank God,” Lois says, “You have to believe that things happen for a reason, even if you don’t understand why.” After Chemofeast last Sunday, Lois drove Blake to his final treatment on Monday. She admits that she will miss the Jimmy Fund Clinic. “Of course, I wish Blake was never diagnosed with cancer,” says Lois. “But our experience here at Dana-Farber is something I would never trade.”
From Leukemia Patient to Caregiver
New Story has been published on https://enzaime.com/leukemia-patient-caregiver/
From Leukemia Patient to Caregiver
Alyssa Ywuc was a 23-year-old nursing student when she was diagnosed with leukemia. After seeing first-hand the work of oncology nurses as a patient, she decided to specialize in oncology nursing. We talked with Alyssa about both sides of the cancer experience – her time as a patient and her future career as a caregiver.
Alyssa’s nurses decorated her room on the day she was supposed to graduate from college. How were you first diagnosed with leukemia? On October 1, 2011, my best friend and I were watching her nieces. I picked up the 1-year-old and I suddenly felt my heart literally beating out of my chest. I quickly put her down and sat for a minute. Being a senior in Northeastern University’s nursing program, I knew immediately to check my pulse. My normal pulse was around 60 beats per minute, but that day, my pulse was 120. My best friend drove me to the emergency room. I had a fever and my heart rate was 196. The nurses and doctors performed tests on me then transferred me to another hospital – thinking I had a heart problem. Once at the other hospital, the doctor came in (we were just expecting him to introduce himself) and he starts talking about oncology and said there’s a good chance I had leukemia. My family and I were blown away. The next day I was diagnosed with acute lymphoblastic leukemia and transferred to Brigham and Women’s Hospital. Because I had been healthy my entire life, this was a shock to everyone. How have you managed the last year of diagnosis and treatment? The past 12 months have been challenging, but I have learned so much about myself and the type of nurse I want to become. I believe that everything happens for a reason and that I was diagnosed with leukemia for a reason as well. Before my diagnosis, I felt that I was invincible; nothing bad could ever happen to me. Now, I don’t take a single day for granted. I know how very precious life is and how important all of my family and friends are. Dana-Farber means so much to me. I owe my life to them, literally. I feel so lucky to live close to the most amazing hospitals in Boston. I am currently participating in a study along with my treatment, and I hope that all of the research that the doctors are doing will help future patients. What are three words that you would use to describe being a patient at Dana-Farber? Appreciative, inspired, and positive. Being diagnosed with cancer is something that everyone hopes never happens to them; however, the experience I have had with Dana Farber has been nothing but positive. The staff puts in extra effort to explain everything to me so I know exactly what to expect during different procedures and stages of my treatment. What advice would you give to a newly diagnosed cancer patient? Treasure every day. Enjoy the good days and know that the bad days won’t last too long; you will get through them. Don’t be afraid and ashamed to wear gloves and a mask out in public – especially during the beginning parts of treatment. Your health comes before any of the stares and comments that other people might have. Dana Farber is the absolute best place to be treated for cancer; you are in the right place. One of the things that helped me the most was to keep my sense of humor during my treatment. Cancer is a serious disease, but I believe that you still have to be yourself during the treatment. Continuing my education during treatment gave me something else to focus on other than being sick. What inspired you to become an oncology nurse? Since I was young, I wanted to be a nurse, but all through nursing school I kept going back and forth between which type of nurse I wanted to be. I can now say that without a doubt I want to become an oncology nurse. I used to picture cancer patients as depressed and sad all the time. I now know that they aren’t different and are so appreciative for their treatment and their lives. The nurses, doctors and staff at both Brigham and Women’s Hospital and at Dana-Farber – and especially the staff on Yawkey 8 — have been beyond caring and compassionate to me. I aspire to be just like each and every one of them. This spring I took three required classes and I was even able to walk with my class at graduation this past May (even though I received a blank diploma). My “graduation day” for Northeastern University was on a morning of a chemo appointment. When I came to Dana Farber for my appointment, one of the nurse’s aides directed me to “my” room. The room was decorated with graduation window decals, balloons, a cake, and a graduation stuffed animal dog with signatures and notes on it from all the staff. I couldn’t believe all that my nurse and the staff had done for me. I will finish my final class (my senior practicum) in the spring and will be able to get my official diploma in May.
Diana Suffered from acute lymphoblastic leukemia
New Story has been published on http://enzaime.com/diana-suffered-acute-lymphoblastic-leukemia/
Diana Suffered from acute lymphoblastic leukemia
In April 2016, Diana got dressed up to celebrate her long-awaited quinceañera. But for Diana and her family, this moment went beyond the festivities. Just a year before, Diana’s future was uncertain after her family received devastating news.
When Diana was 14 years old, her parents noticed she was sleeping more than usual. “It really surprised us, because Diana’s always been a very active girl,” said her mother, Nidia. Just weeks later, tests in their home country of Honduras revealed Diana suffered from acute lymphoblastic leukemia. The family traveled to St. Jude Children’s Research Hospital® for Diana’s treatment and care. “We wanted Diana to be at the best hospital,” said Nidia. “St. Jude is an oasis. It’s a place that gives you hope.” At St. Jude, Diana’s treatment includes two-and-a-half years of chemotherapy.
Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20% to more than 80% since it opened more than 50 years ago. St. Jude is working to drive the overall survival rate for childhood cancer to 90%, and we won’t stop until no child dies from cancer.
St. Jude is an oasis. It’s a place that gives you hope.
Nidia, Diana’s Mother
“Here at St. Jude, you’ll find everything you need to move forward,” said Nidia. “As parents, we only have to worry about Diana’s health.”
This fall, Diana will start the tenth grade. When she grows up, she wants to be a doctor.
Patient like Nick, Cancer Changes Life Forever in the Blink of an Eye
New Story has been published on http://enzaime.com/patient-like-nick-cancer-changes-life-forever-blink-eye/
Patient like Nick, Cancer Changes Life Forever in the Blink of an Eye
A diagnosis of cancer can come unexpectedly and at any moment, and for St. Jude patients like Nick, cancer changes life forever in the blink of an eye. In the summer of 2014, 14-year-old Nick, a promising basketball star with dreams of playing professionally, was competing in basketball camps across the country. As the summer progressed, Nick became exceptionally tired — and stayed that way. He went to the pediatrician for bloodwork. Everyone was at a loss for words when the doctor said Nick’s blood showed signs of cancer and told them to go immediately to St. Jude Children’s Research Hospital.
Hours later, Nick arrived at St. Jude to a diagnosis of acute lymphoblastic leukemia (ALL), a cancer of the blood that requires two-and-a-half years of chemotherapy to treat.
Families never receive a bill from St. Jude for treatment, travel, housing or food — because all a family should worry about is helping their child live. We had no idea (that we would never receive a bill from St. Jude). It took on a whole new meaning for my family. It meant a lot. It was one less thing that we had to worry about.
Nick’s mom True to this promise, St. Jude covered all costs so Nick’s family could solely focus on saving his life. His mom said, “We had no idea. It took on a whole new meaning for my family. It meant a lot. It was one less thing that we had to worry about.”
During treatment, Nick formed lasting relationships with his medical team, fellow patients and even basketball stars, such as Mike Conley of the Memphis Grizzlies. Speaking about the positive environment at St. Jude while battling ALL, Nick said, “It’s a hospital, but you don’t feel like that when you walk inside. You see all the kids playing and laughing. It’s a great place, a great environment.” Nick also formed a desire to give back to the hospital that saved his life. He created a team comprised of more than 120 friends, family and basketball teammates for the St. Jude Walk/Run to End Childhood Cancer. Asked how it feels, as a patient, to help find a cure for cancer by joining the St. Jude Walk/Run to End Childhood Cancer, Nick replied, “I feel truly blessed, because I do see some kids in St. Jude who can’t walk or run, and I know they really would want to. So I’m doing this for those inside that building.”
Along with participating in the St. Jude Walk/Run to End Childhood Cancer for multiple years, Nick has also hosted toy drives for the kids of St. Jude and has plans to release original music, with proceeds going to St. Jude.
In March of 2017, Nick celebrated his end of treatment with a No More Chemo party, surrounded by his medical team and loved ones. Nick has returned to basketball and is now a junior in high school.
Kaelyn suffered from acute lymphoblastic leukemia, a type of blood cancer
New Story has been published on http://enzaime.com/kaelyn-suffered-acute-lymphoblastic-leukemia-type-blood-cancer/
Kaelyn suffered from acute lymphoblastic leukemia, a type of blood cancer
For several weeks in late 2009, Kaelyn was in and out of the doctor’s office. Her pediatrician, believing she had a virus, prescribed antibiotics, but after two rounds, Kaelyn was still unwell. Then her parents, Krystal and Cal, noticed she had developed new, alarming symptoms. The veins on her face had come to the surface, and a knot appeared on her neck. Blood work soon revealed Kaelyn suffered from acute lymphoblastic leukemia, a type of blood cancer. “We were in shock,” Cal said. “It was one of the hardest things I’ve had to hear.”
At St. Jude Children’s Research Hospital, Kaelyn underwent two-and-a-half years of chemotherapy. She responded well to treatment, and her cancer went into remission. St. Jude has helped push the overall survival rate for childhood cancer from less than 20% when we first opened our doors to 80% today. We won’t stop until no child dies from cancer.
St. Jude is a place where hope abounds. We’re thankful to be part of that family.
Kaelyn’s dad, Cal Now out of treatment, Kaelyn visits St. Jude for regular checkups. She has had some lingering physical pain in her legs and feet from treatment, but Kaelyn doesn’t let anything slow her down. She’s a straight A student who counts math and writing among her favorite classes. She takes piano lessons and is also active in her church’s youth group.
“St. Jude means so much to our family,” said Cal. “If it hadn’t been for the dedication of so many, we wouldn’t have Kaelyn. St. Jude is a place where hope abounds. We’re thankful to be part of that family.”
Kaelyn loves taking care of and encouraging younger kids, and recently told her parents that when she grows up, she wants to be a Child Life Specialist.